Globeflex Capital’s Edwards Lifesciences EW Stock Holding History

Globeflex Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$182K	Hold	2,015	–	–	0.02%	317
2026 Q1	$161K	Hold	2,015	–	–	0.02%	319
2025 Q4	$172K	Hold	2,015	–	–	0.03%	321
2025 Q3	$157K	Hold	2,015	–	–	0.02%	327
2025 Q2	$158K	Hold	2,015	–	–	0.01%	334
2025 Q1	$146K	Buy	+2,015	New	+$144K	0.01%	335
2021 Q4	–	Sell	-27	Closed	-$3K	–	473
2021 Q3	$3K	Hold	27	–	–	﹤0.01%	428
2021 Q2	$3K	Hold	27	–	–	﹤0.01%	435
2021 Q1	$2K	Hold	27	–	–	﹤0.01%	440
2020 Q4	$2K	Hold	27	–	–	﹤0.01%	455
2020 Q3	$2K	Hold	27	–	–	﹤0.01%	450
2020 Q2	$2K	Hold	27	–	–	﹤0.01%	474
2020 Q1	$2K	Hold	27	–	–	﹤0.01%	478
2019 Q4	$2K	Hold	27	–	–	﹤0.01%	482
2019 Q3	$2K	Hold	27	–	–	﹤0.01%	469
2019 Q2	$2K	Buy	+27	New	+$1.63K	﹤0.01%	458
2017 Q3	–	Sell	-12,504	Closed	-$493K	–	404
2017 Q2	$493K	Hold	12,504	–	–	0.12%	245
2017 Q1	$392K	Hold	12,504	–	–	0.09%	300
2016 Q4	$391K	Hold	12,504	–	–	0.1%	290
2016 Q3	$502K	Buy	+12,504	New	+$471K	0.13%	248

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Globeflex Capital's EW Position: Q2 2026 in Review

Globeflex Capital held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,015 shares worth $182K. The position accounts for 0.02% of the portfolio, ranked #317.

Globeflex Capital first reported a position in EW in Q3 2016 and has held it in 20 quarters since. The position peaked at $502K in Q3 2016. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Globeflex Capital held 2,015 shares of Edwards Lifesciences worth $182K as of Q2 2026.
Globeflex Capital left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.02% of Globeflex Capital's portfolio in Q2 2026, its #317 holding.
Globeflex Capital first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 20 quarters since.
Globeflex Capital's Edwards Lifesciences position peaked at $502K in Q3 2016.
1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.